|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | ONE JOHNSON & JOHNSON PLAZA |
Address2 | |
| City | NEW BRUNSWICK |
State | NJ |
Zip Code | 08933 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 20686-12
|
||||||||
|
6. House ID# 303480000
|
||||||||
| TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Clifford Holland, Corporate Vice President, Government Affairs and Policy |
Date | 10/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
- HR 1249, "The America Invents Act", regarding all provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Nau |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
- Issues related to dextromethorphan
- Issues related to Pseudoephedrine
- Issues related to the regulation of Cosmetic Products.
- Issues relating to the McNeil recall of over the counter medications
- HR 2359, "Safe Cosmetics Act of 2011", regarding all provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Darrel |
Jodrey |
|
|
|
Don |
Bohn |
|
|
|
Gregory |
Aronin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
- Issues related to chemicals in the environment
- Issues related to the Toxic Substances Control Act
- S. 847, "Safe Chemicals Act of 2011", regarding all provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Darrel |
Jodrey |
|
|
|
Gregory |
Aronin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
- Issues related to ensuring quality of supply chain for FDA regulated products.
- Issues related to Accountable Care Organizations.
- Issues related to Physician Payment Sunshine provisions.
- Issues generating antibiotic incentives.
- Issues regarding personalized medicine
- Issues related to the Medical Device User Fee Program.
- Issues related to the Better Act
- Issues related to the Personalized Medicine Bill
- Issues related to Diagnostics.
- S. 1001, "Safe Doses Act", regarding all provisions.
- HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions.
- Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions.
- Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit.
- Issues related to maintaining the biosimilars statute without changes.
- HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions.
- HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions.
- Physician Drug User Fee Act, regarding all provisions
- MODERN Cures Act, regarding all provisions.
- Personalized Medicine Incentives and Regulation.
- Issues related to Alzheimer's research.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Darrel |
Jodrey |
|
|
|
Mark |
Reese |
|
|
|
Brian |
Burns |
|
|
|
Jane |
Adams |
|
|
|
Kimberly |
Davis |
|
|
|
Lauryl |
Jackson |
|
|
|
Julie |
Cohen |
|
|
|
Charles |
Nau |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
- Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit.
- HR 905/ S 733, "To Amend Part B or Title XVIII of the Social Security Act to exclude customary prompt pay discounts from Manufacturers to Wholesalers from the average sales price for drugs & biologicals under Medicare", regarding all provisions.
- HR 1041, "The Fairness in Medicare Bidding Act", regarding all provisions.
- HR 1041, "Fairness in Medicare Bidding Act", regarding all provisions.
- Medicare Part D Letter
- HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions.
- S 668, "Health Care Bureaucrats Elimination Act", regarding all provisions.
- Issues related to Physician-owned Companies.
- S 1468/ HR 2787, "Medicare Diabetes Self-Management Training Act of 2011", regarding all provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Darrel |
Jodrey |
|
|
|
Mark |
Reese |
|
|
|
Kimberly |
Davis |
|
|
|
Lauryl |
Jackson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
- Issues regarding tax reform.
- HR 605, "The Patients' Freedom to Choose Act", regarding all provisions.
- HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions.
- HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions.
- HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions.
- S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions.
- S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions.
- HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions
- Issues related to tax legislation.
- Issues related to the President's proposed "Job Bill" (2011)
- S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions.
- S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions.
- HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Don |
Bohn |
|
|
|
Jane |
Adams |
|
|
|
Darrel |
Jodrey |
|
|
|
Brian |
Burns |
|
|
|
David |
Kavanaugh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
- HR 5, "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011", regarding all provisions.
- HR 675, "Strengthening Medicare Anti-Fraud Measures Act of 2011", regarding all provisions.
- Issues regarding Health Courts
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Gregory |
Aronin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
- Issues regarding the theft of medical products.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Reese |
|
|
|
Julie |
Cohen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
- Korea-US Free Trade Agreement
- Issues related to current and future trade negotiations.
- TransPacific Partnership trade negotiations.
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
David |
Kavanaugh |
|
Counsel, Sen. Ensign; Deputy Asst. Secretary, Dept. |
|
David |
Kavanaugh |
|
of Treasury; General Counsel, Ways & Means |
|
David |
Kavanaugh |
|
Committee; Professional Staff, Ways & Means |
|
David |
Kavanaugh |
|
Committee; Legislative Asst., Rep. Thomas |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
- Issues related to ADAP funding.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Nau |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |